About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Metastatic Malignant Chondroid Syringoma: A Rare Case Scenario
Mahalaxmi Aal1, Vijay Bhaskar Lakshman1, Pradeep Kumar Karumanchi1, Gopinath Kodaganur Srinivas2, Amarendra Shankarappa2, Bindiya Vijayan1
Departments of 1Radiation Oncology and 2Surgical Oncology, Health Care Global Enterprises Ltd, Bengaluru, Karnataka, India.
Corresponding Author:
Dr. Mahalaxmi Aal
Email: mahalakshmi.aall@gmail.com
Received: 15-JUN-2019 Accepted: 04-DEC-2019 Published Online: 30-JAN-2020
DOI: http://dx.doi.org/10.17659/01.2020.0006
Abstract
Background: Malignant chondroid syringoma is one of the rarest clinical entities. It is a mixed cutaneous tumor with propensity for local invasion resulting in multiple local recurrences. Malignant chondroid syringoma has female predilection common in extremities. We are presenting this case in view of its rare presentation among the population, and unique clinical course. Case Report: A 38-year-old lady, known case of malignant chondroid syringoma of the left hand was treated for multiple local recurrences with excision, local radiation therapy and chemotherapy. She developed distant visceral metastasis over a span of 20 years after the primary diagnosis. Conclusion: Malignant chondroid syringoma has potential for both local recurrence and distant metastasis over a prolonged clinical course with on and off remission period. Because of its longer clinical course patients are recommended to be on regular follow up.
Keywords : Computed Tomography, Biopsy, Mastectomy, Microcystic adnexal carcinoma, Skin Neoplasms.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025